| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.003 | 1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.068 | 0.2 |